Identification of the major degradation pathways of ticagrelor

J Pharm Biomed Anal. 2015 Feb:105:74-83. doi: 10.1016/j.jpba.2014.11.046. Epub 2014 Dec 4.

Abstract

Ticagrelor is a direct-acting and reversible P2Y12-adenosine diphosphate (ADP) receptor blocker used as antiplatelet drug. Forced degradation under various stress conditions was carried out. The degradation products have been detected and identified by high-pressure liquid chromatography multistage mass spectrometry (LC-MS(n)) along with high-resolution mass spectrometry. C18 XTerra MS column combined with a linear gradient mobile phase composed of a mixture of 10 mM acetate ammonium/acetonitrile was shown suitable for drug and impurity determinations and validated as a stability indicating method. Structural elucidation of the degradation products relied on MS(n) studies and accurate mass measurements giving access to elemental compositions. Up to nine degradation products resulting from oxidation/auto-oxidation, S-dealkylation and N-dealkylation have been identified, covering a range of possible degradation pathways for derivatives with such functional groups. Kinetics was also studied in order to assess the molecule's shelf-life and to identify the most important degradation factors.

Keywords: Degradation kinetic; Degradation pathways; Electrospray orbitrap mass spectrometry; LC stability-indicating assay method; Ticagrelor.

MeSH terms

  • Adenosine / analogs & derivatives*
  • Adenosine / analysis
  • Adenosine / chemistry
  • Adenosine / radiation effects
  • Chromatography, Reverse-Phase / instrumentation
  • Chromatography, Reverse-Phase / methods*
  • Drug Contamination
  • Drug Stability
  • Hot Temperature
  • Hydrolysis
  • Limit of Detection
  • Mass Spectrometry / methods*
  • Molecular Structure
  • Oxidation-Reduction
  • Photolysis
  • Platelet Aggregation Inhibitors / analysis*
  • Platelet Aggregation Inhibitors / chemistry
  • Platelet Aggregation Inhibitors / radiation effects
  • Purinergic P2Y Receptor Antagonists / analysis*
  • Purinergic P2Y Receptor Antagonists / chemistry
  • Purinergic P2Y Receptor Antagonists / radiation effects
  • Reproducibility of Results
  • Ticagrelor

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Ticagrelor
  • Adenosine